Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 1
1973 1
1974 1
1976 1
1979 3
1980 2
1987 2
1988 2
1989 2
1994 2
1995 2
1996 1
1997 1
1998 1
1999 2
2000 1
2002 1
2003 2
2004 2
2005 5
2006 14
2007 5
2008 7
2009 2
2010 7
2011 12
2012 12
2013 18
2014 12
2015 20
2016 25
2017 15
2018 21
2019 26
2020 31
2021 33
2022 22
Text availability
Article attribute
Article type
Publication date

Search Results

272 results
Results by year
Filters applied: . Clear all
Page 1
Trial of Tocilizumab in Giant-Cell Arteritis.
Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N. Stone JH, et al. Among authors: rech j. N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849. N Engl J Med. 2017. PMID: 28745999 Free article. Clinical Trial.
Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome.
Rom O, Liu Y, Liu Z, Zhao Y, Wu J, Ghrayeb A, Villacorta L, Fan Y, Chang L, Wang L, Liu C, Yang D, Song J, Rech JC, Guo Y, Wang H, Zhao G, Liang W, Koike Y, Lu H, Koike T, Hayek T, Pennathur S, Xi C, Wen B, Sun D, Garcia-Barrio MT, Aviram M, Gottlieb E, Mor I, Liu W, Zhang J, Chen YE. Rom O, et al. Among authors: rech jc. Sci Transl Med. 2020 Dec 2;12(572):eaaz2841. doi: 10.1126/scitranslmed.aaz2841. Sci Transl Med. 2020. PMID: 33268508 Free PMC article.
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study.
Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, Pellet P, Delicha EM, Pricop L, Mpofu S; FUTURE 1 study group. Mease PJ, et al. Among authors: rech j. ACR Open Rheumatol. 2020 Jan;2(1):18-25. doi: 10.1002/acr2.11097. Epub 2019 Nov 14. ACR Open Rheumatol. 2020. PMID: 31943974 Free PMC article.
Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.
Kampylafka E, Simon D, d'Oliveira I, Linz C, Lerchen V, Englbrecht M, Rech J, Kleyer A, Sticherling M, Schett G, Hueber AJ. Kampylafka E, et al. Among authors: rech j. Arthritis Res Ther. 2019 Jul 26;21(1):178. doi: 10.1186/s13075-019-1957-0. Arthritis Res Ther. 2019. PMID: 31349876 Free PMC article. Clinical Trial.
[S2k guidelines: management of large-vessel vasculitis].
Schirmer JH, Aries PM, Balzer K, Berlit P, Bley TA, Buttgereit F, Czihal M, Dechant C, Dejaco C, Garske U, Henes J, Holle JU, Holl-Ulrich K, Lamprecht P, Nölle B, Moosig F, Rech J, Scheuermann K, Schmalzing M, Schmidt WA, Schneider M, Schulze-Koops H, Venhoff N, Villiger PM, Witte T, Zänker M, Hellmich B. Schirmer JH, et al. Among authors: rech j. Z Rheumatol. 2020 Nov;79(Suppl 3):67-95. doi: 10.1007/s00393-020-00893-1. Z Rheumatol. 2020. PMID: 33156399 Review. German. No abstract available.
Anti-TNFs in axial spondyloarthritis.
Kocijan R, Muschitz C, Rech J. Kocijan R, et al. Among authors: rech j. Wien Med Wochenschr. 2015 Jan;165(1-2):10-3. doi: 10.1007/s10354-014-0338-1. Epub 2015 Jan 9. Wien Med Wochenschr. 2015. PMID: 25572548 Review.
Biological agents in psoriatic arthritis.
Kocijan R, Muschitz C, Rech J. Kocijan R, et al. Among authors: rech j. Wien Med Wochenschr. 2015 Jan;165(1-2):36-9. doi: 10.1007/s10354-014-0300-2. Epub 2014 Sep 10. Wien Med Wochenschr. 2015. PMID: 25205184 Review.
272 results